Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:15 PM.
Here’s what investors need to know about the announcement.
Earnings
Milestone Pharmaceuticals missed estimated earnings by 8.33%, reporting an EPS of $-0.39 versus an estimate of $-0.36.
Revenue was down $15.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.06 which was followed by a 5.26% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Milestone Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
